TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 0 | 3 | 1 | 5 | 7 | -7 | 1 |
| S | %wins | 50 | 0 | 50 | 50 | 0 | 100 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/2/16 16:54 | 11/2/16 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Lazarus Rochelle B | NY | D | S.d | -1,181 | 59.06 | 33 | -20 | -76 | 6 | D | 9 | 11 | 10 | 4 | -5 | -4 | -3 | -3 | -1 | 3 | 3 | 10 | 9 | ||
11/26/14 12:40 | 11/26/14 | MRK | Merck & Co. Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Lazarus Rochelle B | NY | D | S.d | -596 | 59.63 | 33 | -10 | -61 | 6 | D | 44 | 23 | 4 | -1 | 8 | 0 | 0 | 0 | 1 | 2 | -2 | -1 | 4 | -7 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |